Provided by Tiger Trade Technology Pte. Ltd.

Caris Life Sciences, Inc.

26.27
+1.696.88%
Post-market: 26.500.2300+0.88%19:53 EDT
Volume:6.39M
Turnover:165.58M
Market Cap:7.41B
PE:70.62
High:26.60
Open:24.73
Low:24.32
Close:24.58
52wk High:42.50
52wk Low:14.19
Shares:282.15M
Float Shares:116.00M
Volume Ratio:1.40
T/O Rate:5.51%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3720
EPS(LYR):-3.2200
ROE:20.13%
ROA:8.77%
PB:12.53
PE(LYR):-8.16

Loading ...

Company Profile

Company Name:
Caris Life Sciences, Inc.
Exchange:
NASDAQ
Establishment Date:
2008
Employees:
1846
Office Location:
750 West John Carpenter Freeway,Suite 800,Irving,Texas,United States
Zip Code:
75039
Fax:
866 479 4925
Introduction:
Caris Life Sciences, Inc. is a leading patient-centered next-generation artificial intelligence technology biology company and precision medicine pioneer. It develops and commercializes innovative solutions to transform health care through the large-scale use of comprehensive molecular information and AI/ML algorithms. Its entire portfolio of precision medicine solutions is designed to benefit patients, with an initial focus on oncology and serving the clinical, academic and biopharmaceutical markets.

Directors

Name
Position
Brian J. Brille
Executive Vice President and Vice Chairman
David D. Halbert
Chairman and Chief Executive Officer and Founder
George H. Poste
Vice Chairman
Jonathan Knowles
Vice Chairman
Danny Phillips
Director
David Fredrickson
Director
Jeffrey Vacirca
Director
Jon S. Halbert
Director
Joseph E. Gilliam
Director
Laura I. Johansen
Director
Lloyd B. Minor
Director
Peter M. Castleman
Director

Shareholders

Name
Position
David D. Halbert
Chairman and Chief Executive Officer and Founder
J. Russel Denton
General Counsel and Secretary and Senior Vice President
Luke Power
Chief Accounting Officer and Chief Financial Officer and Senior Vice President
Brian J. Brille
Executive Vice President and Vice Chairman
David Spetzler
President